AbbVie - 6 Year Stock Price History | ABBV

Historical daily share price chart and data for AbbVie since 2013 adjusted for splits. The latest closing stock price for AbbVie as of April 25, 2019 is 79.34.
  • The all-time high AbbVie stock price is 117.97, which is 48.7% above the current share price.
  • The AbbVie 52-week high stock price is 102.77, which is 29.5% above the current share price.
  • The AbbVie 52-week low stock price is 76.88, which is 3.1% below the current share price.
  • The average AbbVie stock price for the last 52 weeks is 88.31.
AbbVie Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 81.4993 88.1176 89.6582 77.1400 79.3400 -12.85%
2018 94.5984 93.5581 117.9732 76.8795 91.0407 -0.98%
2017 70.6432 57.2249 93.3680 55.5910 91.9419 60.13%
2016 54.8375 50.8179 61.2211 45.6488 57.4175 9.88%
2015 54.0369 56.2497 62.2421 42.5791 52.2557 -6.46%
2014 46.7933 42.9680 59.5108 39.0216 55.8656 27.97%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $116.045B $32.753B
AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $373.460B 16.93
Pfizer (PFE) United States $234.364B 13.12
Merck (MRK) United States $201.486B 17.22
Novartis AG (NVS) Switzerland $179.764B 15.53
Eli Lilly (LLY) United States $122.227B 21.22
Novo Nordisk (NVO) Denmark $118.193B 19.12
Sanofi (SNY) France $104.035B 12.84
GlaxoSmithKline (GSK) United Kingdom $99.050B 13.01
AstraZeneca (AZN) United Kingdom $98.074B 11.19
Bristol-Myers Squibb (BMY) United States $72.907B 11.21